Feasibility of Monotherapy by Rituximab Without Additional Desensitization in ABO-incompatible Living-Donor Liver TransplantationHidekazu Yamamoto, Yukihiro Inomata, Seiichi Kawabata et al.|Transplantation|2017Cited by 31